Cargando…

Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control

BACKGROUND: Numerous epidemiology studies on dyslipidemia have been conducted in China. However, a nationally representative estimate for dyslipidemia prevalence is lacking. The aim of this study is to appraise the nationwide prevalence, awareness, treatment, and control rates of dyslipidemia in adu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yuanxiu, Gao, Lin, Xie, Xiaoping, Tan, Seng Chuen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219092/
https://www.ncbi.nlm.nih.gov/pubmed/25371655
http://dx.doi.org/10.1186/s12963-014-0028-7
_version_ 1782342528682426368
author Huang, Yuanxiu
Gao, Lin
Xie, Xiaoping
Tan, Seng Chuen
author_facet Huang, Yuanxiu
Gao, Lin
Xie, Xiaoping
Tan, Seng Chuen
author_sort Huang, Yuanxiu
collection PubMed
description BACKGROUND: Numerous epidemiology studies on dyslipidemia have been conducted in China. However, a nationally representative estimate for dyslipidemia prevalence is lacking. The aim of this study is to appraise the nationwide prevalence, awareness, treatment, and control rates of dyslipidemia in adults in China. METHODS: We performed a systematic review of the related observational studies published since 2003 by searching English and Chinese literature databases. Meta-analyses were conducted in eligible studies using a random effect model to summarize the dyslipidemia prevalence, awareness, treatment, and control rates. Heterogeneity and publication bias were analyzed. Sensitivity analyses were performed to explain heterogeneity and examine the impact of study quality on the results of meta-analyses. RESULTS: Thirty-eight papers were included for meta-analyses, with a total sample size of 387,825. The prevalence, awareness, treatment, and control rates of dyslipidemia were 41.9% (95% CI: 37.7% – 46.2%), 24.4% (95% CI: 14.4% – 38.4%), 8.8% (95% CI: 7.7% – 10.0%), and 4.3% (95% CI: 4.1% – 4.5%), respectively. The prevalence of hypercholesterolemia, hypertriglyceridemia, mixed hyperlipidemia, low levels of high-density lipoprotein cholesterol, and high levels of low-density lipoprotein cholesterol were 10.1% (95% CI: 5.8% – 16.9%), 17.7% (95% CI: 14.0% – 22.1%), 5.1% (95% CI: 3.1% – 8.2%), 11.0% (95% CI: 8.0% – 15.0%), and 8.8% (95% CI: 4.1% – 17.8%), respectively. Sensitivity analyses revealed that males had a higher prevalence of dyslipidemia (43.2%) than females (35.6%). Study samples of age 30 and above in the eastern region tended to have higher prevalence of dyslipidemia. The quality of the studies has a slight impact on the pooled estimates. CONCLUSIONS: The overall pooled prevalence of dyslipidemia in Chinese adults was estimated to be 41.9%, with males having a higher rate than females. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-014-0028-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4219092
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42190922014-11-05 Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control Huang, Yuanxiu Gao, Lin Xie, Xiaoping Tan, Seng Chuen Popul Health Metr Review BACKGROUND: Numerous epidemiology studies on dyslipidemia have been conducted in China. However, a nationally representative estimate for dyslipidemia prevalence is lacking. The aim of this study is to appraise the nationwide prevalence, awareness, treatment, and control rates of dyslipidemia in adults in China. METHODS: We performed a systematic review of the related observational studies published since 2003 by searching English and Chinese literature databases. Meta-analyses were conducted in eligible studies using a random effect model to summarize the dyslipidemia prevalence, awareness, treatment, and control rates. Heterogeneity and publication bias were analyzed. Sensitivity analyses were performed to explain heterogeneity and examine the impact of study quality on the results of meta-analyses. RESULTS: Thirty-eight papers were included for meta-analyses, with a total sample size of 387,825. The prevalence, awareness, treatment, and control rates of dyslipidemia were 41.9% (95% CI: 37.7% – 46.2%), 24.4% (95% CI: 14.4% – 38.4%), 8.8% (95% CI: 7.7% – 10.0%), and 4.3% (95% CI: 4.1% – 4.5%), respectively. The prevalence of hypercholesterolemia, hypertriglyceridemia, mixed hyperlipidemia, low levels of high-density lipoprotein cholesterol, and high levels of low-density lipoprotein cholesterol were 10.1% (95% CI: 5.8% – 16.9%), 17.7% (95% CI: 14.0% – 22.1%), 5.1% (95% CI: 3.1% – 8.2%), 11.0% (95% CI: 8.0% – 15.0%), and 8.8% (95% CI: 4.1% – 17.8%), respectively. Sensitivity analyses revealed that males had a higher prevalence of dyslipidemia (43.2%) than females (35.6%). Study samples of age 30 and above in the eastern region tended to have higher prevalence of dyslipidemia. The quality of the studies has a slight impact on the pooled estimates. CONCLUSIONS: The overall pooled prevalence of dyslipidemia in Chinese adults was estimated to be 41.9%, with males having a higher rate than females. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12963-014-0028-7) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-28 /pmc/articles/PMC4219092/ /pubmed/25371655 http://dx.doi.org/10.1186/s12963-014-0028-7 Text en © Huang et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Huang, Yuanxiu
Gao, Lin
Xie, Xiaoping
Tan, Seng Chuen
Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
title Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
title_full Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
title_fullStr Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
title_full_unstemmed Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
title_short Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control
title_sort epidemiology of dyslipidemia in chinese adults: meta-analysis of prevalence, awareness, treatment, and control
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219092/
https://www.ncbi.nlm.nih.gov/pubmed/25371655
http://dx.doi.org/10.1186/s12963-014-0028-7
work_keys_str_mv AT huangyuanxiu epidemiologyofdyslipidemiainchineseadultsmetaanalysisofprevalenceawarenesstreatmentandcontrol
AT gaolin epidemiologyofdyslipidemiainchineseadultsmetaanalysisofprevalenceawarenesstreatmentandcontrol
AT xiexiaoping epidemiologyofdyslipidemiainchineseadultsmetaanalysisofprevalenceawarenesstreatmentandcontrol
AT tansengchuen epidemiologyofdyslipidemiainchineseadultsmetaanalysisofprevalenceawarenesstreatmentandcontrol